[1] |
. Alzheimers Dement,2021,17(3):327-406.
|
[2] |
Jeong S. Molecular and cellular basis of neurodegeneration in Alzheimer′s disease[J]. Mol Cells,2017,40(9):613-620.
|
[3] |
Sweeney MD,Montagne A,Sagare AP,et al. Vascular dysfunction — The disregarded partner of Alzheimer′s disease[J]. Alzheimers Dement,2019,15(1):158-167.
|
[4] |
Elahi FM,Casaletto KB,la Joie R,et al. Plasma biomarkers of astrocytic and neuronal dysfunction in early- and late-onset Alzheimer′s disease[J]. Alzheimers Dement,2020,16(4):681-695.
|
[5] |
Nation DA,Sweeney MD,Montagne A,et al. Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction[J]. Nat Med,2019,25(2):270-276.
|
[6] |
Serlin Y,Shelef I,Knyazer B,et al. Anatomy and physiology of the blood-brain barrier[J]. Semin Cell Dev Biol,2015,38:2-6.
|
[7] |
Cai ZY,Qiao PF,Wan CQ,et al. Role of blood-brain barrier in Alzheimer′s disease[J]. J Alzheimers Dis,2018,63(4):1223-1234.
|
[8] |
Sweeney MD,Sagare AP,Zlokovic BV. Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders[J]. Nat Rev Neurol,2018,14(3):133-150.
|
[9] |
Iadecola C. The neurovascular unit coming of age:a journey through neurovascular coupling in health and disease[J]. Neuron,2017,96(1):17-42.
|
[10] |
Zenaro E,Piacentino G,Constantin G. The blood-brain barrier in Alzheimer′s disease[J]. Neurobiol Dis,2017,107:41-56.
|
[11] |
Erd? F,Denes L,de Lange E. Age-associated physiological and pathological changes at the blood-brain barrier:a review[J]. J Cereb Blood Flow Metab,2017,37(1):4-24.
|
[12] |
Song J,Choi SM,Whitcomb DJ,et al. Adiponectin controls the apoptosis and the expression of tight junction proteins in brain endothelial cells through AdipoR1 under beta amyloid toxicity[J]. Cell Death Dis,2017,8(10):e3102.
|
[13] |
Mangialasche F,Solomon A,Winblad B,et al. Alzheimer′s disease:clinical trials and drug development[J]. Lancet Neurol,2010,9(7):702-716.
|
[14] |
Breijyeh Z,Karaman R. Comprehensive review on Alzheimer′s disease:causes and treatment[J]. Molecules,2020,25(24):5789.
|
[15] |
Xu Z,Chen S,Wang Y,et al. Neuroprotective effects of silk fibroin hydrolysate against Aβ25-35 induced cytotoxicity in SH-SY5Y cells and primary hippocampal neurons by regulating ROS inactivation of PP2A[J]. J Funct Foods,2018,45:100-109.
|
[16] |
Yao SY,Xu Z,Chen S,et al. Silk fibroin hydrolysate improves memory impairment via multi-target function[J]. J Funct Foods,2022,89:104942.
|
[17] |
Greene C,Hanley N,Campbell M. Claudin-5:gatekeeper of neurological function[J]. Fluids Barriers CNS,2019,16(1):3.
|
[18] |
Yamazaki Y,Shinohara M,Shinohara M,et al. Selective loss of cortical endothelial tight junction proteins during Alzheimer′s disease progression[J]. Brain,2019,142(4):1077-1092.
|
[19] |
Huang XW,Hussain B,Chang JL. Peripheral inflammation and blood-brain barrier disruption:effects and mechanisms[J]. CNS Neurosci Ther,2021,27(1):36-47.
|
[20] |
Voirin AC,Perek N,Roche F. Inflammatory stress induced by a combination of cytokines (IL-6,IL-17,TNF-α) leads to a loss of integrity on bEnd.3 endothelial cells in vitro BBB model[J]. Brain Res,2020,1730:146647.
|
[21] |
Feng S,Zou L,Wang HJ,et al. RhoA/ROCK-2 pathway inhibition and tight junction protein upregulation by catalpol suppresses lipopolysaccaride-induced disruption of blood-brain barrier permeability[J]. Molecules,2018,23(9):2371.
|
[22] |
Wang L,Zhang R,Chen J,et al. Baicalin protects against TNF-α-induced injury by down-regulating miR-191a that targets the tight junction protein ZO-1 in IEC-6 cells[J]. Biol Pharm Bull,2017,40(4):435-443.
|
[23] |
Burek M,F?rster CY. Cloning and characterization of the murine claudin-5 promoter[J]. Mol Cell Endocrinol,2009,298(1/2):19-24.
|
[24] |
Hayden MS,Ghosh S. Regulation of NF-κB by TNF family cytokines[J]. Semin Immunol,2014,26(3):253-266.
|
[25] |
Caldwell AB,Cheng Z,Vargas JD,et al. Network dynamics determine the autocrine and paracrine signaling functions of TNF[J]. Genes Dev,2014,28(19):2120-2133.
|
[26] |
Zhang Q,Lenardo MJ,Baltimore D. 30 years of NF-κB:a blossoming of relevance to human pathobiology[J]. Cell,2017,168(1/2):37-57.
|
[27] |
McNamara AJ,Danthi P. Loss of IKK subunits limits NF-κB signaling in reovirus-infected cells[J]. J Virol,2020,94(10):e00382-e00320.
|
[28] |
Chen YJ,Chan DC,Chiang CK,et al. Advanced glycation end-products induced VEGF production and inflammatory responses in human synoviocytes via RAGE-NF-κB pathway activation[J]. J Orthop Res,2016,34(5):791-800.
|
[29] |
Ding B,Lin CH,Liu Q,et al. Tanshinone IIA attenuates neuroinflammation via inhibiting RAGE/NF-κB signaling pathway in vivo and in vitro[J]. J Neuroinflammation,2020,17(1):302.
|